Discontinuation of Initial Antiretroviral Therapy in Clinical Practice-Reference-Cited by-同舟云学术

Discontinuation of Initial Antiretroviral Therapy in Clinical Practice

Published:2016-03-01 Issue:3 Volume:71 Page:263-271
ISSN:1525-4135
Container-title:JAIDS Journal of Acquired Immune Deficiency Syndromes
language:en
Short-container-title:

Author:

Di Biagio Antonio,Cozzi-Lepri Alessandro,Prinapori Roberta,Angarano Gioacchino,Gori Andrea,Quirino Tiziana,De Luca Andrea,Costantini Andrea,Mussini Cristina,Rizzardini Giuliano,Castagna Antonella,Antinori Andrea,d'Arminio Monforte Antonella

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Pharmacology (medical),Infectious Diseases

Reference43 articles.

1. . Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy.;Gulick;N Engl J Med,1997

2. . A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team.;Hammer;N Engl J Med,1997

3. . Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators.;Palella;N Engl J Med,1998

4. . The effect of combined antiretroviral therapy on the overall mortality of HIV-infected individuals.;Ray;AIDS,2010

5. . Long-lasting recovery in CD4 T-cell function and viral-load reduction after highly active antiretroviral therapy in advanced HIV-1 disease.;Li;Lancet,1998

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Characterization and outcomes of difficult-to-treat patients starting modern first-line ART regimens: Data from the ICONA cohort;International Journal of Antimicrobial Agents;2024-01

2. Pharmacokinetics and tolerability of the maturation inhibitor GSK3640254 coadministered with darunavir/ritonavir and/or etravirine in healthy adults;British Journal of Clinical Pharmacology;2023-09-20

3. Self‐reported neuropsychiatric adverse reactions in people receiving bictegravir combined with emtricitabine/tenofovir alafenamide;Journal of Pharmacy Practice and Research;2023-06-03

4. Examination of the Reasons for Change in Treatment in Patients İnfected with Human Immunodeficiency Virus;Mediterranean Journal of Infection Microbes and Antimicrobials;2023-02-07

5. Long-Term Effectiveness of Rilpivirine-Based Single-Tablet Regimens in a Seven-Year, Two-Center Observational Cohort of People Living with HIV;AIDS Research and Human Retroviruses;2022-06-01